Yenal Dundar

7PUBLICATIONS
16CO-AUTHORS
Counselling, wellbeing and community servicesAvionicsNeural engineeringGene and molecular therapyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 29, 2026
Digital front door technologies to pre-assess people before assessment for NHS Talking Therapies [HTE10055]: early value assessment.

|Dec 05, 2023
Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.

Marty Chaplin, Rebecca Bresnahan, Nigel Fleeman

|Sep 21, 2023
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.

Marty Chaplin, Rebecca Bresnahan, Nigel Fleeman

|May 17, 2023
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Rebecca Bresnahan, Rachel Houten, Janette Greenhalgh

|Apr 21, 2023
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Rachel Houten, Nigel Fleeman, James Mahon

|Dec 14, 2019
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine.

Nigel Fleeman, Rachel Houten, Marty Chaplin

Pageof 2

Frequent Collaborators

6 joint publications

Nigel Fleeman

6 joint publications

Sophie Beale

6 joint publications

Angela Boland

5 joint publications

Rachel Houten